Life sciences innovation is a critical growth engine, with regions worldwide competing to turn scientific discovery into global impact. While legacy leaders dominate, emerging ecosystems are shaping new models to accelerate progress. Global leaders like Boston, the Bay Area and the UK continue to set the pace, but rising hubs across Asia and the Middle East are quickly gaining ground. 

Our benchmark reveals how ecosystems succeed across funding, talent and commercialization — and what emerging markets must do to compete globally.

Methodology

L.E.K. Consulting assessed six leading and rising ecosystems (the Bay Area, Boston, the UK Golden Triangle, Shanghai, Singapore and South Korea) across five pillars:

  • Public funding: Public capital that de-risks early innovation
  • Capital markets: Clear exit pathways and diverse investor bases
  • Operational enablers: Streamlined regulation and advanced infrastructure
  • Human & network capital: Experienced talent and cross-sector collaboration
  • Commercial: Market scale and integration into global demand

Figure 1: Scope of ecosystem in analysis

Scope of ecosystem in analysis

Figure 2: Evaluation framework

Evaluation framework

Key insights

  • Global leaders: Boston, the Bay Area and the UK excel across all pillars with balanced, mature ecosystems.
  • Emerging hubs: Singapore, South Korea and Shanghai show rapid progress but face gaps in late-stage capital, global-facing talent and scalable exit pathways.
  • Regional models: Japan, Hong Kong and the GCC bring unique strengths — from research excellence to capital access — but often lack integration and commercialization depth.
     

Figure 3: Evaluation result of Boston, Bay Area, UK, Shanghai, Singapore, and South Korea life science ecosystem

Evaluation result of Boston, Bay Area, UK, Shanghai, Singapore, and South Korea life science ecosystem

Strategic implications

Ecosystem builders should:

  • Pair nondilutive public funding with mechanisms that catalyze private investment.
  • Build globally connected markets to expand exits and M&A momentum.
  • Strengthen talent pipelines and networks to deepen leadership capacity.
  • Focus on commercial scalability to secure long-term viability.

Looking ahead

The race to build competitive life sciences hubs is intensifying. Bold policy choices, coordinated investment and talent-led growth will define the next generation of global leaders. Where does your ecosystem stand — and what steps will you take to stay ahead?

Discover the full benchmark and explore the levers to unlock global competitiveness.

Related Practice
Life Sciences & Pharma

Related Insights